£107.93

Springer Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 1 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 36 days • 36 data points

Historical
Generating forecast...
£107.98 £107.93 £107.94 £107.95 £107.96 £107.97 £107.99 01 May 2026 09 May 2026 18 May 2026 27 May 2026 05 June 2026

Price Distribution

Price distribution over 36 days • 1 price levels

Days at Price
36 days 0 9 18 27 36 £108 Days at Price

Price Analysis

Most common price: £108 (36 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 36 days

Description

Fondation Ipsen sponsored a meeting in Paris in February 2000 on the emerging paradigm-shift in our understanding of the major degenerative diseases which- affect the aging human brain. This book sumarizes our deliberations on some of these major neurodegenerative diseases that are characterized by protein depos- its, and that are due to the pathogenic gain of function of an otherwise normal neuronal protein. For each of the major human neurodegenerative diseases covered in this book -the most prominent being Alzheimer's disease -experimental models are described, including cell culture systems and animal models which range from the round worm, Caenorhabditis elegans, the fruitfly, Drosophila melanogaster, to rodents. Remarkably, in the sporadic forms of these human diseases, only a minor change in the level of production or turn-over of the relevant proteins is sufficient to cause disease in late adult-hood. Neurodegeneration in Alzheimer's disease, for example, usually results in symptoms and signs in the seventh to eighth decades. In contrast, the development of protein deposits in transgenic mice over-expressing the corresponding disease gene parallels the genetic forms of the human diseases in regard to its manifestation occuring half-way through its normal life-span, i. e. about 50 years in humans (the so-called "presenium") and 9 to 12 months in the mouse. Nevertheless, these models have served to elu- cidate many of the pathways underlying the human disease processes, for instance clarifying the neuronal origin of parenchymal and perivascular amyloid in Alzheimer's disease and Creutzfeldt-Jakob disease. From the Back Cover A fundamental change is occurring in the understanding of the major neurodegenerative disorders. Protein aggregation is a common emerging theme in diseases as diverse as Alzheimer's, Creutzfeld-Jakob, Parkinson's, and amyotrophic lateral sclerosis. If valid, then a small number of diagnostic and rational therapeutic strategies will emerge over the next few years, based on the common theme of modulation of the production, turnover and deposition of these aggregating proteins. The book provides insights into the cellular and animal models of these diseases, and how the molecular basis of neurodegeneration has become the preferred target of therapy.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
06 December 2010
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
87% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
86% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£143.49 24 May 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
86% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£77.85 20 May 2026
Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders: Protein Aggregates In Neurodegenerative Disorders (Research And Perspectives In Alzheimer's Disease)
85% match

Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders: Protein Aggregates In Neurodegenerative Disorders (Research And Perspectives In Alzheimer's Disease)

Springer

£140.63 30 May 2026
Protein Degradation in Health and Disease: 29 (Progress in Molecular and Subcellular Biology, 29)
84% match

Protein Degradation in Health and Disease: 29 (Progress in Molecular and Subcellular Biology, 29)

Springer

£73.31 31 May 2026
Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
84% match

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology

Springer

£107.98 28 May 2026
Protein Misfolding and Human Diseases: Deciphering the Central Role of Pathological Aggregation
84% match

Protein Misfolding and Human Diseases: Deciphering the Central Role of Pathological Aggregation

Academic Press

£133.99 25 May 2026
Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
84% match

Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.22 01 Jun 2026
Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)
83% match

Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)

Humana

£75.68 03 Jun 2026
Neurodegenerative Disorders: A Clinical Guide
83% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 26 May 2026
Diabetes, Insulin and Alzheimer's Disease (Research and Perspectives in Alzheimer's Disease)
83% match

Diabetes, Insulin and Alzheimer's Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£107.78 31 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
82% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.83 26 May 2026
The Proteasome in Neurodegeneration
82% match

The Proteasome in Neurodegeneration

Springer

£76.38 29 May 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
82% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 05 Jun 2026
Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3
81% match

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

£110.40 30 May 2026
Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research
81% match

Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research

Springer

£76.38 28 May 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
81% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.05 27 May 2026
81% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Academic Press

£157.99 20 May 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
81% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 29 May 2026
Mitochondrial Dynamics and Neurodegeneration
81% match

Mitochondrial Dynamics and Neurodegeneration

Springer

£107.98 02 Jun 2026
Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)
81% match

Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)

Humana

£103.24 25 May 2026
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)
81% match

Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)

Springer

£50.88 26 May 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
81% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£107.63 26 May 2026
Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)
81% match

Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)

Springer

£165.20 01 Jun 2026